The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | The importance of maintenance therapy for CTCL
Rudolf Stadler
• 15 Oct 2021
Rudolf Stadler, MD, PhD, University Medical Center Minden, Minden, Germany, outlines the role of maintenance therapy in the management of cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
